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Introduction
The ability of red blood cells to facilitate the journey of
oxygen from the atmosphere to the mitochondrion has
been repeatedly demonstrated in a vast literature of mam-
malian physiology. The physical characteristics of red cells
and the properties of their contents allow these cells to
increase the solubility of plasma for oxygen by about 30-
fold. In addition, the affinity of red cells for oxygen is modu-
lated by regional acid–base conditions to favor oxygen
loading at the pulmonary alveolar capillary interface as well
as unloading at the tissue level.
At present there are no clinically available fluids that have
the loading, unloading, and carrying properties of blood.
Promising oxygen-transporting chemicals such as fluoro-
carbons and stroma-free hemoglobin solutions are being
developed and tested in clinical trials but are not available
for routine clinical use [1,2]. Clinically available nonsan-
guinous fluids (colloids and crystalloids) are often used
instead of blood because they increase oxygen delivery to
systemic tissues by increasing cardiac output. However,
these solutions transport much less oxygen than equiva-
lent volumes of blood. In addition, because of their hypo-
oncotic properties, crystalloidal fluids accumulate in
interstitial spaces and can lead to impaired pulmonary gas
exchange and to edema of other tissues. Although labora-
tory and clinical data suggest that hematocrits of 50 or
greater are associated with decreased systemic oxygen
delivery from loading effects of increased viscosity on
cardiac ejection, why do we tolerate lower and even sub-
normal hemoglobin levels in our stressed critically ill
patient population, given the superiority of blood as a
carrier of oxygen?
Safety issues
A heightened awareness of the complications of blood
transfusions has led clinicians to challenge the need to
maintain conventional or normal hematocrit levels in the
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Abstract
Red cells are uniquely designed to transport oxygen and facilitate oxygen uptake by systemic tissues.
Blood transfusions are thus logical therapeutic choices in patients who exhibit signs of oxygen debt. A
small number of studies that have addressed patients with metabolic or physiologic signs of oxygen
debt or regional ischaemia suggest that liberal blood transfusion strategies improve outcome.
Therefore, armed with an understanding of the variety of clinical presentations characterising oxygen
debt, as well as an appreciation of the risks involved, blood transfusions should be considered in all
critically ill patients. This includes the consideration of liberalized hemoglobin triggers and hemoglobin
thresholds in normal ranges.
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care of critically ill patients. These complications include
the transmission of infection (HIV, hepatitis B and C, and
bacterial infections) as well as allergic reactions and
impairment of the immune response [3,4]. In a recent
review of trauma patients, significant decreases in the
number of patients receiving transfusions as well as in the
number of units used have been observed [5]. These
changes were attributed to an increased knowledge of the
complications of blood transfusions by managing clinicians.
Negative studies
Not only is the safety of blood transfusion in question, but
the efficacy of this intervention has been challenged.
Several recent clinical studies suggest that transfusing
critically ill patients to traditional hemoglobin levels might
not improve outcome. For example, a large prospective
study reported by Hebert et al [6] demonstrated that criti-
cally ill patients with various disorders have similar or
improved outcomes when a restrictive approach to trans-
fusion (maintaining hemoglobin levels in the range
7.0–9.0 g/dl) was compared with a more liberal approach
(maintaining hemoglobin levels in the range
10.0–12.0 g/dl). Several additional studies have docu-
mented that restrictive approaches to transfusion are well
tolerated in perioperative surgical patients. In a study of
patients undergoing hip fracture repair reported by Carson
et al [7], no survival advantage could be demonstrated in
patients who received postoperative transfusions, includ-
ing patients with hemoglobin levels of less than 8 g/dl.
Similar findings have been noted in studies of surgical
patients undergoing abdominal aortic surgery [8,9] and
coronary artery bypass surgery [10].
The results of these studies are compelling and suggest
that blood transfusion aiming at traditional hemoglobin
levels might not benefit large numbers of critically ill
patients. Nevertheless, these studies were not designed
to address patients whose regional or global oxygen
demands are not satisfied. In addition, most negative
studies do not address the age of the transfused blood in
the light of observations that blood stored for prolonged
periods has decreased oxygen unloading properties [11].
Supportive studies
Where is the support for the use of blood transfusions in
critically ill patients? Does not a basic understanding of the
physiology of oxygen utilization lead to the hypothesis that
patients with oxygen debt are most likely to benefit from the
superior oxygen-carrying capabilities of blood? Conversely,
is anyone surprised that blood transfusions seem to be
useless or even harmful in critically ill patients who might
not have a problem with oxygen utilization, or in periopera-
tive patients who might have only transient oxygen debts?
Indeed, smaller clinical studies suggest that patients who
have regional impairments in oxygen utilization have an
improved outcome from a liberal approach to blood trans-
fusion. Subsets of patients have been identified who seem
to do better with a liberal rather than a restrictive approach
to transfusion. In a study reported by Hebert et al [12],
improved survival was noted in transfused anemic patients
with cardiac disease in comparison with similar patients
who had not been transfused. In a study of patients with
chronic obstructive pulmonary disease (COPD) and mean
hemoglobin levels of 8.7 ± 0.8 g/dl, Schonhofer et al [13]
reported that weaning off mechanical ventilation was not
achieved until hemoglobin levels of 12.0 g/dl were
achieved with transfused blood. In a subsequent, larger
study, these investigators demonstrated that blood trans-
fusion in COPD patients with hemoglobin levels of less
than 11.0–12.0 g/dl was associated with decreases in
both minute ventilation and work of breathing, presumably
owing to a salutory effect on the respiratory muscles ineffi-
ciently using oxygen [14]. These small clinical studies
stress the need to examine outcomes related to blood
transfusion in groups of critically ill patients with evidence
of systemic or regional oxygen debts.
Stratification according to markers of oxygen
debt
Blood lactate levels, anion gaps, base deficits, pH and
bicarbonate levels are used under appropriate clinical
conditions as markers of oxygen debt, especially in
patients with clinical signs of circulatory shock. These
markers reflect the biochemical changes that ensue when
anaerobic metabolism is present. In a small study of septic
patients, Gilbert et al [15] demonstrated that elevated
lactic acid levels predicted an increase in systemic oxygen
consumption in response to transfused blood, a potentially
beneficial response. This response was not observed in a
comparable group without lactic acidosis. Accordingly, in
the study by Hebert et al [6], which included patients with
mostly normal lactate levels (1.8 ± 1.8 mmol/l in the
restrictive group and 1.8 ± 2.1 mmol/l in the liberal group),
a failure to observe differences in outcome might have
been because neither group had anaerobic metabolism
and thus a need for transfused blood.
Admittedly, lactic acid levels lack both sensitivity and speci-
ficity as clinical markers of anaerobic metabolism. [16,17].
When compared with lactate levels, values such as anion
gaps, base deficits, pH and bicabonate levels are even less
sensitive and specific. Nevertheless, these markers are easy
to obtain in the clinical setting in the absence of more avail-
able sensitive and specific markers of anaerobic metabo-
lism. Large clinical studies stratifying patients according to
these markers and with the appropriate statistical power
have the potential to provide relevant results that will help to
clarify the role of blood transfusion in the critically ill.
Some investigators have used abnormalities in systemic
oxygen extraction ratio, systemic oxygen consumption andCritical Care    Vol 5 No 2 Haupt
delivery, mixed venous oxygen saturation and tension as
well as the presence of oxygen supply dependence in
response to a clinical intervention as surrogate markers for
conditions associated with oxygen debt. These values are
also lacking in specificity but have led to promising prelim-
inary results. Conrad et al [18] demonstrated in septic
shock patients that a low systemic oxygen extraction ratio
(less than 24%) predicted an increase in oxygen con-
sumption in response to blood transfusion. In a recent
study of cardiac surgical patients reported by Casutt et al
[19], an increase in systemic oxygen uptake in response to
blood transfusion was predicted by pre-transfusion oxygen
consumption and delivery values.
Stratification according to regional signs of
oxygen debt
Although lactate levels and oxygen-derived values reflect
global abnormalities in the utilizaton of oxygen, there is a
need to address the value of blood transfusions in patients
with regional ischemia. Global parameters might be
normal in the face of regional abnormalities in oxygen uti-
lization. In a study reported by Oud and Haupt [20],
patients with severe circulatory shock exhibited tonometri-
cally demonstrated splanchnic ischemia that continued
after lactic acid and related acid–base measurements
were restored to normal levels through resuscitative inter-
ventions. Studies evaluating the response of patients with
splanchnic ischemia to blood transfusion are warranted.
Newer and better methods of detecting cardiac and neu-
rologic ischemia will also increase the opportunities to
assess the effects of blood transfusion in patients with
coronary and cerebral vascular disease.
Conclusions
The risks and benefits of blood transfusion need thought-
ful consideration for all types of critically ill patients. More
focused evaluations of specific patient populations will
help to clarify the use of blood transfusions in critically ill
patients. In the meantime, special consideration for blood
transfusion should be given to patients with clinical and
biochemical evidence of oxygen debt. Problems with the
unloading properties of stored blood need to be
addressed. More liberal hemoglobin or hematocrit triggers
should be considered in patients with coronary artery
disease, continuing cardiac ischemia, and patients with
COPD who are failing to wean off mechanical ventilation.
Although more speculative, a liberal approach to blood
transfusion should be considered in patients who have
signs of brain, splanchnic, or extremity ischemia.
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